Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Canonical Wnt Signaling Pathway

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

Non-Canonical Wnt Signaling Pathways

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Skeleton and Calcium Homeostasis

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pigmented region transcriptomics identifies molecular pathways potentially associated with microbial transport in the female squid accessory Nidamental Gland.

Scientific reports·2026

Same author

A marine-derived fungal genome of Annulohypoxylon annulatoides reveals AT-rich isochores with putative regulatory functions.

G3 (Bethesda, Md.)·2026

Same author

Bone phenotype in a mouse model of Classical Ehlers Danlos syndrome with Col5a1 haploinsufficiency.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Same author

Bottom-up sol-gel synthesis of 2D lead glycolate and oxide nanostructures towards electrochemical ozone production.

Nanoscale·2026

Same author

Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA.

Dermatology and therapy·2026

Same author

Leveraging generative AI to transform statistical analysis plan authoring in clinical trials.

Clinical trials (London, England)·2026

Search research articles

Related Experiment Video

Updated: Feb 28, 2026

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Published on: July 21, 2023

Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis.

Kyu Sang Joeng¹, Yi-Chien Lee¹, Joohyun Lim¹

¹Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

The Journal of Clinical Investigation

|June 20, 2017

Summary

WNT1 loss in osteocytes causes osteogenesis imperfecta (OI) and osteoporosis. Targeting WNT1 signaling with anti-sclerostin antibody (Scl-Ab) improves bone mass and reduces fractures in OI models.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Related Experiment Videos

Last Updated: Feb 28, 2026

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Published on: July 21, 2023

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Area of Science:

Bone Biology
Endocrinology
Genetics

Background:

Mutations in WNT1 gene are linked to osteogenesis imperfecta (OI) and early-onset osteoporosis.
WNT1 is a crucial Wnt ligand for bone homeostasis, but its precise role and location in bone are not fully understood.

Purpose of the Study:

To elucidate the mechanism by which WNT1 influences bone metabolism.
To investigate the function of osteocyte-derived WNT1 in bone development and homeostasis.
To evaluate anti-sclerostin antibody (Scl-Ab) as a potential treatment for WNT1-related bone disorders.

Main Methods:

Generated osteoblast-specific and osteocyte-specific WNT1 loss- and gain-of-function mouse models.
Assessed bone mass, fracture rates, and osteoblast activity in the generated mouse models.
Administered anti-sclerostin antibody (Scl-Ab) to a mouse model of global WNT1 loss.

Main Results:

WNT1 deletion in osteocytes led to low bone mass and spontaneous fractures, mimicking OI.
WNT1 overexpression in osteocytes enhanced bone formation by increasing osteoblast number and activity, partly via mTORC1 signaling.
Scl-Ab treatment significantly improved bone mass and reduced fracture incidence in WNT1-deficient mice.

Conclusions:

WNT1-related OI and osteoporosis result from impaired osteoblast function due to reduced WNT1 signaling in osteocytes.
Osteocytes act as an anabolic source of Wnt, contributing to bone development and homeostasis.
Scl-Ab represents a promising genotype-specific therapeutic strategy for WNT1-related bone diseases.